# Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Study · id `cardio:ct-nct03756103` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03756103](<https://clinicaltrials.gov/study/NCT03756103>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03756103

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT03756103. Randomized; double masking; primary purpose treatment. Start 2019-01-11 (actual); primary completion 2020-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT03756103, source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)
- Started: 2019-01-11 (actual) (ClinicalTrials.gov record NCT03756103, source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)
- Primary completion: 2020-06-30 (actual) (ClinicalTrials.gov record NCT03756103, source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)
- Completion: 2020-06-30 (actual) (ClinicalTrials.gov record NCT03756103, source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03756103, source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03756103-2021-11-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
- Condition: Hypertension,Essential
- Intervention (Drug): SPH3127 tablet Dose 1
- Intervention (Drug): SPH3127 tablet Dose 2
- Intervention (Drug): SPH3127 tablet Dose 3
- Intervention (Drug): SPH3127 tablet Placebo
- Lead sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: R&G Pharma Studies Co.,Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Shanghai Pharmaceuticals Holding Co., Ltd (`cardio:org-shanghai-pharmaceuticals-holding-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension (`cardio:pubmed-38632457`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5400958f55f9ebcebe981c599396f1ebef44926a46141a6826b85efe9d8a8436
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
